Frazier Lifesciences Acquisition Corporation Stock
Stocks
NAMS
NL00150012L7
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
2026-08-20
|
5-day change | 1st Jan Change | ||
| 27.78 EUR | -2.63% |
|
+2.97% | -20.81% |
| 08-14 | Newamsterdam Pharma Company N.V. Announces Executive Changes | CI |
| 08-06 | RBC Adjusts NewAmsterdam Pharma PT to $50 From $51, Maintains Outperform Speculative Risk Rating | MT |
| Market Cap | 2.85B 3.33B 2.67B 2.44B 4.59B 319B 4.65B 31.55B 12.3B 160B 12.51B 12.24B 530B | P/E 2026 * |
-14.5x | P/E 2027 * | -15.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2.43B 2.84B 2.27B 2.08B 3.91B 271B 3.96B 26.86B 10.48B 136B 10.65B 10.42B 451B | EV / Sales 2026 * |
98.7x | EV / Sales 2027 * | 18.8x |
| Free-Float |
99.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Frazier Lifesciences Acquisition Corporation
| 1 day | -2.63% | ||
| 1 week | +2.97% | ||
| Current month | -0.04% | ||
| 1 month | -12.37% | ||
| 3 months | -21.61% | ||
| 6 months | -21.92% | ||
| Current year | -20.81% |
| 1 week | 26.43 |  | 28.76 |
| 1 month | 25.74 | | 31.29 |
| Current year | 25.74 | | 42.2 |
| 1 year | 23.05 | | 42.2 |
| 3 years | 5.63 | | 42.2 |
| 5 years | 5.63 | | 42.2 |
| 10 years | 5.63 | | 42.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Davidson
CEO | Chief Executive Officer | 69 | 2022-10-31 |
Mayur Somaiya
DFI | Director of Finance/CFO | 52 | 2023-10-22 |
John Kastelein
CTO | Chief Tech/Sci/R&D Officer | 72 | 2022-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Davidson
BRD | Director/Board Member | 69 | 2022-10-31 |
John Kastelein
BRD | Director/Board Member | 72 | 2022-10-31 |
James Topper
BRD | Director/Board Member | 64 | 2022-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/20/26 | Fiscal year | Controller/Auditor | 315,000 | 0.2695% | ||
| 3/2/26 | Fiscal year | Chief Executive Officer | 1,331,121 | 1.1577% | ||
| 2/24/26 | Fiscal year | Chief Executive Officer | 918,879 | 0.8104% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.63% | +2.97% | +11.12% | +154.86% | 3.33B | |
| -3.00% | +2.27% | +73.26% | +109.90% | 72.12B | |
| +1.90% | +23.53% | +59.48% | +94.82% | 65.85B | |
| +5.12% | +25.22% | +5.13% | -5.86% | 29.28B | |
| +0.55% | +1.64% | -4.63% | +480.92% | 27.47B | |
| +2.74% | +12.98% | +54.92% | +25.77% | 26.7B | |
| +0.47% | +6.12% | +37.01% | -15.31% | 20.06B | |
| +1.82% | -6.67% | +251.36% | +388.91% | 18.22B | |
| +0.94% | +3.36% | +15.30% | +548.19% | 16.4B | |
| +0.73% | +5.54% | +39.99% | +151.77% | 13.4B | |
| Average | +0.86% | +7.82% | +54.29% | +193.40% | 29.28B | |
| Weighted average by Cap. | +0.70% | +9.41% | +57.49% | +157.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 24.62M 28.74M 23.04M 21.09M 39.58M 2.75B 40.1M 272M 106M 1.38B 108M 106M 4.57B | 122M 142M 114M 104M 196M 13.62B 199M 1.35B 526M 6.84B 535M 523M 22.63B |
| Net income | -202M -236M -189M -173M -325M -22.58B -329M -2.23B -871M -11.34B -886M -867M -37.52B | -195M -227M -182M -167M -313M -21.76B -317M -2.15B -840M -10.93B -854M -835M -36.15B |
| Net Debt | -424M -495M -396M -363M -681M -47.32B -690M -4.68B -1.83B -23.77B -1.86B -1.82B -78.63B | -556M -650M -521M -477M -894M -62.15B -906M -6.15B -2.4B -31.22B -2.44B -2.39B -103B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | €27.87 | +0.32% | 525,432 |
| 26-08-20 | €27.78 | -2.63% | 744,358 |
| 26-08-19 | €28.53 | +4.70% | 1,032,236 |
| 26-08-18 | €27.25 | +1.30% | 948,916 |
| 26-08-17 | €26.90 | -0.30% | 834,973 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NAMS Stock
Select your edition
All financial news and data tailored to specific country editions
